Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway
FEBS Open Bio · 2023
DOI: 10.1002/2211-5463.13582 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2023. Verfasst von Bratati Mukherjee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer and Angiogenesis Research Lab, School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India. Hauptthemen laut MEDLINE: Fibroblast Growth Factor 2, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Atomic Energy, Government of India, National Institute of Science Education and Research.
Abstract (Originalsprache)
Identifying novel targets that control both tumorigenesis and angiogenesis can aid in developing a more potent anti‐angiogenic therapeutic strategy. We previously reported that reduction of FRG1 is associated with increased p38‐MAPK signaling in prostate cancer and with elevated MEK–ERK signaling in breast cancer. Here, we reveal the role of FRG1 in tumor angiogenesis. Our findings demonstrate that depleted FRG1 levels enhance the proliferation, migration, and tubule formation of HUVECs in a paracrine manner, and this was further substantiated in multiple animal models. Mechanistically, FRG1 depletion activated the expression of FGF2 in breast cancer cells, which triggered the ERK/AKT cascade in endothelial cells. As FRG1 affects multiple tumorigenic properties and it is upstream of FGF2, it can be explored as a therapeutic target that is less prone to resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer and Angiogenesis Research Lab, School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, India.
- Training School Complex, Homi Bhabha National Institute, Anushaktinagar, India.
ORCID-Profile: Bratati Mukherjee, Manjusha Dixit
Förderung
- Department of Atomic Energy, Government of India
- National Institute of Science Education and Research
Zitieren
APA
Mukherjee, B., Brahma, P., Mohapatra, T., Chawla, S., & Dixit, M. (2023). Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway. FEBS Open Bio. https://doi.org/10.1002/2211-5463.13582
Vancouver
Mukherjee B, Brahma P, Mohapatra T, Chawla S, Dixit M. Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway. FEBS Open Bio. 2023. doi:10.1002/2211-5463.13582
BibTeX
@article{Mukherjee2023,
author = {Mukherjee, Bratati and Brahma, Pratush and Mohapatra, Talina and Chawla, Saurabh and Dixit, Manjusha},
title = {Reduced FRG1 expression promotes angiogenesis via activation of the FGF2 ‐mediated ERK / AKT pathway},
journal = {FEBS Open Bio},
year = {2023},
doi = {10.1002/2211-5463.13582}
}
EUVIMED